Participant-centric Trial Will Test if Antiviral Paxlovid Can Help With Long COVID
Researchers are still in the dark on the mechanisms underlying and how to treat long COVID. A new clinical trial using the oral antiviral Paxlovid will provide urgently needed insights for COVID long-haulers and their providers.
Yale doctor discusses COVID anniversary and our status now
Friday marks the third anniversary of the first person in the United States to be diagnosed with COVID. Since then the toll the virus has taken has been tremendous. 1.1 million deaths nationwide and 11,899 deaths in Connecticut.Source: WTNH News 8
Long COVID: Skeptics Are Wrong, Researchers Say
WHRY collaborator Akiko Iwasaki, PhD, joins Fiona Lowenstein, editor of “The Long COVID Survival Guide,” to discuss patients who say they’re suffering from Long COVID for as much as two years after their acute phase of the disease. Listen to their discussion as part of "Conversations on Health Care."Source: Community Health Center
Will Long COVID Research Provide Answers for Poorly Understood Diseases Like ME/CFS?
ME/CFS (myalgic encephalomyelitis/chronic fatigue syndrome) is a highly disabling, severe condition that has been largely overlooked and even questioned as an illness by physicians and biomedical researchers for decades. But now, scientists including Yale's Akiko Iwasaki and Harlan Krumholz are finding parallels between post-infection long COVID and ME/CFS.
‘Prime and Spike’ Nasal Vaccine Strategy Helps Combat COVID
The new “prime” and “spike” approach may help prevent breakthrough infections of vaccinated individuals by bolstering immune response within the mucosal lining of the respiratory tract, which are the first cells attacked by COVID-19.Source: YaleNews
FDA says new COVID-19 vaccines will protect against current strains
EG.5, nicknamed Eris after the Greek goddess of chaos who indirectly started the Trojan War, makes up approximately 20.6% of current infections, while FL 1.5.1 comprises 13.3%. Both are Omicron variants. “The two strains, EG.5 and XBB.1.5, are not identical, but they're pretty close,” said Scott Roberts, an infectious disease specialist for Yale Medicine. “My strong suspicion is that, given the genetic similarities, there will still be a good degree of protection from the booster."Source: Washington Examiner
Researchers Are Testing Paxlovid as a Treatment for Long COVID
Long COVID currently affects millions of people in the U.S. Symptoms can include brain fog, tremors, sleep disorders, and shortness of breath. The National Institutes of Health (NIH) and other academic medical centers recently launched clinical trials aimed at finding treatments for long COVID. Researchers think that there may be different causes of long COVID symptoms in different people, which is why they are conducting different clinical trials in many centers around the country.Source: Verywell Health
Yale Physicians Reflect on Covid, Three Years Later
It’s been more than three years since the COVID pandemic began, causing over six million deaths worldwide (as of April 2023). While things have largely returned to normal thanks to vaccines, lockdowns, and public health measures and with the Public Health Emergency recently ending, life is a “new normal.” No one who has come out on the other side of the height of the pandemic has remained unaffected, whether physically, emotionally, or both. This is particularly true for the frontline healthcare workers who cared for very sick patients despite the fear of becoming ill themselves.